Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Mar 8;31(6):170-173.
doi: 10.1016/j.jccase.2025.02.007. eCollection 2025 Jun.

Fatal coronary vasospasm following oral triptan intake

Affiliations
Case Reports

Fatal coronary vasospasm following oral triptan intake

Idir-Yanis Djellal et al. J Cardiol Cases. .

Abstract

Triptans, commonly used for migraine treatment, induce vasoconstriction by activating 5HT1B/1D and 5HT1F receptors. Although several cases of coronary vasospasm associated with sumatriptan have been reported, few describe life-threatening arrhythmias and cardiac arrest. We present a case of fatal coronary vasospasm caused by triptan use in a young patient with minimal cardiovascular risk. A 30-year-old man with morbid obesity was admitted for unstable angina. He reported chest pain episodes starting one month earlier, coinciding with the initiation of oral sumatriptan for migraines. On the second day of hospitalization, he took 100 mg of sumatriptan. Ninety minutes later, he developed recurrent chest pain that progressed to cardiac arrest caused by a ventricular arrhythmia storm. Left anterior descending artery vasospasm with ST-segment elevation myocardial infarction was identified, and intracoronary nitrate and adenosine relieved the spasm. However, resuscitation was ineffective due to morbid obesity, leaving the patient in profound cardiogenic shock, followed by distributive shock from prolonged low-flow time. Despite maximal hemodynamic support, he succumbed to multiorgan failure. This case highlights the potentially fatal cardiovascular risk of triptans, even in low-risk patients, and underscores the need to discontinue triptans at the first sign of chest pain.

Learning objectives: Coronary vasospasm, a rare but severe complication of triptans, can lead to life-threatening arrhythmias and cardiac arrest, even in patients with low cardiovascular risk. Diagnosing vasospasm is challenging, as angiograms may appear normal during symptom-free intervals. This case highlights the need for heightened clinical suspicion when chest pain follows triptan use, emphasizing the importance of recognizing this risk to ensure prompt management and avoid fatal outcomes.

Keywords: Acute coronary syndrome; Coronary vasospasm; Triptans; Ventricular fibrillation.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Fig. 1
Fig. 1
Electrocardiogram of the patient at admission to the emergency department during pain-free interval (A) and the following day during chest pain (B).
Fig. 2
Fig. 2
Coronary angiograms showing the vasospasm of distal left anterior descending artery (A) and its progressive improvement after intracoronary administration of nitrates and adenosine (B and C).

References

    1. Ferrari M.D., Roon K.I., Lipton R.B., Goadsby P.J. Oral triptans (serotonin 5-HT 1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet. 2001;358:1668–1675. - PubMed
    1. Goadsby P.J., Holland P.R., Martins-Oliveira M., Hoffmann J., Schankin C., Akerman S. Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev. 2017;97:553–622. - PMC - PubMed
    1. Otsuka T., Räber L. Acute coronary syndrome triggered by nitro-resistant triptan-induced coronary spasm. Eur Heart J. 2019;40:1919. - PubMed
    1. Okonkwo K., Ojha U. Vasospasm induced myocardial ischaemia secondary to sumatriptan use. BMJ Case Rep. 2020;13 - PMC - PubMed
    1. MacIntyre P.D., Bhargava B., Hogg K.J., Gemmill J.D., Hillis W.S. Effect of subcutaneous sumatriptan, a selective 5HT1 agonist, on the systemic, pulmonary, and coronary circulation. Circulation. 1993;87:401–405. - PubMed

Publication types

LinkOut - more resources